141 related articles for article (PubMed ID: 36764494)
1. Synthetic glucocorticoids instead of hydrocortisone do not increase mineralocorticoid needs in adult patients with salt wasting congenital adrenal hyperplasia.
Auer MK; Paizoni L; Nowotny H; Lottspeich C; Tschaidse L; Schmidt H; Bidlingmaier M; Reisch N
J Steroid Biochem Mol Biol; 2023 Jun; 230():106271. PubMed ID: 36764494
[TBL] [Abstract][Full Text] [Related]
2. Modified-release hydrocortisone is associated with lower plasma renin activity in patients with salt-wasting congenital adrenal hyperplasia.
Tschaidse L; Reisch N; Arlt W; Brac de la Perriere A; Linden Hirschberg A; Juul A; Mallappa A; Merke DP; Newell-Price JDC; Perry CG; Prete A; Rees DA; Stikkelbroeck NMML; Touraine PA; Coope H; Porter J; Ross RJM; Quinkler M
Eur J Endocrinol; 2023 Jan; 188(1):. PubMed ID: 36654495
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia.
Ng SM; Stepien KM; Krishan A
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012517. PubMed ID: 32190901
[TBL] [Abstract][Full Text] [Related]
4. Effect of carbenoxolone on the plasma renin activity and hypothalamic-pituitary-adrenal axis in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Irony I; Cutler GB
Clin Endocrinol (Oxf); 1999 Sep; 51(3):285-91. PubMed ID: 10469007
[TBL] [Abstract][Full Text] [Related]
5. Treatment of congenital adrenal hyperplasia in children aged 0-3 years: a retrospective multicenter analysis of salt supplementation, glucocorticoid and mineralocorticoid medication, growth and blood pressure.
Neumann U; van der Linde A; Krone RE; Krone NP; Güven A; Güran T; Elsedfy H; Poyrazoglu S; Darendeliler F; Bachega TASS; Balsamo A; Hannema SE; Birkebaek N; Vieites A; Thankamony A; Cools M; Milenkovic T; Bonfig W; Costa EC; Atapattu N; de Vries L; Guaragna-Filho G; Korbonits M; Mohnike K; Bryce J; Ahmed SF; Voet B; Blankenstein O; Claahsen-van der Grinten HL
Eur J Endocrinol; 2022 Apr; 186(5):587-596. PubMed ID: 35290211
[TBL] [Abstract][Full Text] [Related]
6. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM; Simm D; Beier C; Dörr HG
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[TBL] [Abstract][Full Text] [Related]
7. Growth of patients with congenital adrenal hyperplasia due to 21-hydroxylase in infancy, glucocorticoid requirement and the role of mineralocorticoid therapy.
Sellick J; Aldridge S; Thomas M; Cheetham T
J Pediatr Endocrinol Metab; 2018 Sep; 31(9):1019-1022. PubMed ID: 30173205
[TBL] [Abstract][Full Text] [Related]
8. Reinstitution of mineralocorticoid therapy in congenital adrenal hyperplasia. Effects on control and growth.
Jansen M; Wit JM; van den Brande JL
Acta Paediatr Scand; 1981 Mar; 70(2):229-33. PubMed ID: 7015786
[TBL] [Abstract][Full Text] [Related]
9. Blood pressure, fludrocortisone dose and plasma renin activity in children with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency followed from birth to 4 years of age.
Bonfig W; Schwarz HP
Clin Endocrinol (Oxf); 2014 Dec; 81(6):871-5. PubMed ID: 24818525
[TBL] [Abstract][Full Text] [Related]
10. Molecular testing in congenital adrenal hyperplasia due to 21α-hydroxylase deficiency in the era of newborn screening.
Sarafoglou K; Lorentz CP; Otten N; Oetting WS; Grebe SK
Clin Genet; 2012 Jul; 82(1):64-70. PubMed ID: 21534945
[TBL] [Abstract][Full Text] [Related]
11. Congenital Adrenal Hyperplasia in Children: The Relationship between Plasma Renin Activity and Hypertension.
Lubis SM; Soesanti F; Hidayati EL; Aap BT
Iran J Med Sci; 2024 Jun; 49(6):377-383. PubMed ID: 38952640
[TBL] [Abstract][Full Text] [Related]
12. Sodium Chloride Supplementation Is Not Routinely Performed in the Majority of German and Austrian Infants with Classic Salt-Wasting Congenital Adrenal Hyperplasia and Has No Effect on Linear Growth and Hydrocortisone or Fludrocortisone Dose.
Bonfig W; Roehl F; Riedl S; Brämswig J; Richter-Unruh A; Fricke-Otto S; Hübner A; Bettendorf M; Schönau E; Dörr H; Holl RW; Mohnike K
Horm Res Paediatr; 2018; 89(1):7-12. PubMed ID: 29073619
[TBL] [Abstract][Full Text] [Related]
13. International practice of corticosteroid replacement therapy in congenital adrenal hyperplasia: data from the I-CAH registry.
Bacila I; Freeman N; Daniel E; Sandrk M; Bryce J; Ali SR; Yavas Abali Z; Atapattu N; Bachega TA; Balsamo A; Birkebæk N; Blankenstein O; Bonfig W; Cools M; Costa EC; Darendeliler F; Einaudi S; Elsedfy HH; Finken M; Gevers E; Claahsen-van der Grinten HL; Guran T; Güven A; Hannema SE; Higham CE; Iotova V; van der Kamp HJ; Korbonits M; Krone RE; Lichiardopol C; Luczay A; Mendonca BB; Milenkovic T; Miranda MC; Mohnike K; Neumann U; Ortolano R; Poyrazoglu S; Thankamony A; Tomlinson JW; Vieites A; de Vries L; Ahmed SF; Ross RJ; Krone NP
Eur J Endocrinol; 2021 Apr; 184(4):553-563. PubMed ID: 33460392
[TBL] [Abstract][Full Text] [Related]
14. 24-hour ambulatory blood pressure profile in patients with congenital adrenal hyperplasia--a preliminary report.
de Silva KS; Kanumakala S; Brown JJ; Jones CL; Warne GL
J Pediatr Endocrinol Metab; 2004 Aug; 17(8):1089-95. PubMed ID: 15379420
[TBL] [Abstract][Full Text] [Related]
15. Effect of androgen excess and glucocorticoid exposure on metabolic risk profiles in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Paizoni L; Auer MK; Schmidt H; Hübner A; Bidlingmaier M; Reisch N
J Steroid Biochem Mol Biol; 2020 Mar; 197():105540. PubMed ID: 31730799
[TBL] [Abstract][Full Text] [Related]
16. Salt wasting in simple virilizing congenital adrenal hyperplasia.
Frisch H; Battelino T; Schober E; Baumgartner-Parzer S; Nowotny P; Vierhapper H
J Pediatr Endocrinol Metab; 2001; 14(9):1649-55. PubMed ID: 11795656
[TBL] [Abstract][Full Text] [Related]
17. Mineralocorticoid replacement therapy in salt-wasting congenital adrenal hyperplasia.
Lang K; Quinkler M; Kienitz T
Clin Endocrinol (Oxf); 2023 Aug; ():. PubMed ID: 37564007
[TBL] [Abstract][Full Text] [Related]
18. Do All Patients with Congenital Adrenal Hyperplasia Need to Be on Hydrocortisone Three Times a Day in Order to Have Normal Growth?
Logan LA; Nebesio TD; Eckert GJ; Eugster EA
Horm Res Paediatr; 2022; 95(5):461-464. PubMed ID: 35649383
[TBL] [Abstract][Full Text] [Related]
19. Requirement of mineralocorticoid in congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency.
Hochberg Z; Benderly A; Kahana L; Zadik Z
J Clin Endocrinol Metab; 1986 Jul; 63(1):36-40. PubMed ID: 3011843
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure in children and adolescents with congenital adrenal hyperplasia (21-hydroxylase deficiency): a preliminary report.
Roche EF; Charmandari E; Dattani MT; Hindmarsh PC
Clin Endocrinol (Oxf); 2003 May; 58(5):589-96. PubMed ID: 12699440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
